Journal of the Korea Convergence Society (한국융합학회논문지)

Korea Convergence Society (한국융합학회)
권호 표지
DOI QR코드

DOI QR Code

Brief Review on the Processes for RNA-Platform Vaccine Production

RNA 플랫폼 백신 제조공정 고찰 연구

  • Roh, Hyungmin (Department of Chemical and Environmental Technology, Inha Technical College) ;
  • Oh, Kyeongseok (Department of Chemical and Environmental Technology, Inha Technical College)
  • 노형민 (인하공업전문대학 화공환경과) ;
  • 오경석 (인하공업전문대학 화공환경과)
  • Received : 2021.05.27
  • Accepted : 2021.08.20
  • Published : 2021.08.28
Download PDF
⟨ Previous Next ⟩

Abstract

Among the Covid-19 vaccine platforms, mRNA-platform vaccines are summarized qualitatively in this paper. Manufacturing mRNA vaccines consist of serial processes; the preparation process of DNA template, the transcription of mRNA, nanoemulsion process, and the fill and finish unit combined with formulation stages. It is noticeable that major players are collaborated for producing mRNA vaccines. In particular, the nanoemulsion process is recognized to the key process requiring formulated lipid materials to protect modified mRNA until they arrive in intracellular cytosol. It is known that the nanoemulsion process adapts well-designed microfluidic devices. We expect that the nanoemulsion process will stimulate pharmaceutical industries to develop diverse applications.

국내 승인된 코로나-19 백신 중, mRNA 플랫폼 기반 백신의 제조공정을 중심으로 살펴보았다. 제조공정은 크게 DNA 주형 제조공정, mRNA 전사공정, 나노에멀젼화 공정, 제형화, 그리고 완제공정으로 이루어져 있다. 이 공정들은 여러 제약사 및 위탁생산회사와 협업으로 진행되고 있다. 이 중 핵심공정인 나노에멀젼화 공정은 mRNA 보호역할을 위해 지질 성분들이 필요하며, 혼합공정에는 microfluidic device를 활용하는 것으로 알려져 있다. 나노에멀젼화 공정 기술은 향후 다양한 의약품 개발에 자극제 역할을 할 것으로 기대된다.

Keywords

References

  1. J. Cohen. (2021). Unveiling 'Warp Speed', the White House's America-first Push for a Coronavirus Vaccine. Science. doi:10.1126/science.abc7056
  2. M. Bird. (2021-05-06). A Global Operation Warp Speed is Needed to Unlock World-Wide Vaccine Production. Wall Street Journal. https://www.wsj.com/articles/a-global-operation-warp-speed-is-needed-to-unlock-world-wide-vaccine-production-11620285441 (accessed May 24, 2021)
  3. C. Calisher et al. (2020). Statement in Support of the Scientists, Public Health Professionals, and Medical Professionals of China Combatting COVID-19. The Lancet, 395(10226), E42-E43. https://doi.org/10.1016/S0140-6736(20)30418-9
  4. K. Oh. (2018). A Study on the Publication of Open Access Artcles. Journal of the Korean Convergence Society, 11(5), 145-151. DOI: 10.15207/JKCS.2020.11.5.145
  5. J. Gale & L. Beyer. (2021). What's the Best Covid Vaccine? Why It's not So Simple. Bloomberg. https://www.bloomberg.com/news/articles/2021-03-10/what-s-the-best-covid-vaccine-why-it-s-not-so-simple-quicktake
  6. M. Terry. (2021). Updated Comparing COVID-19 Vaccines: Timelines, Types and Prices. Biospace. https://www.biospace.com/article/comparing-covid-19-vaccines-pfizer-biontech-moderna-astrazeneca-oxford-j-and-j-russia-s-sputnik-v/
  7. F. Amant & F. Krammer. (2020). SARS-Cov-2 Vaccines: Status Report. Immunity, 52(4), 583-589. DOI:https://doi.org/10.1016/j.immuni.2020.03.007
  8. World Health Organization. (2020). COVID-19 Vaccines. WHO Guidance Document. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines (accessed May 24, 2021)
  9. European Medicines Agency. (2020). COVID-19 Vaccines. EPA Human Regulatory. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/covid-19-vaccines
  10. European Medicines Agency. (2021). Assessment Report COVID-19 Vaccine AstraZeneca. EMA Human Regulatory. https://www.ema.europa.eu/en/documents/assessment-report/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-public-assessment-report_en.pdf
  11. European Medicines Agency. (2020). Assessment Report COVID-19 Vaccine Janssen.. EMA Human Regulatory. https://www.ema.europa.eu/en/documents/assessment-report/covid-19-vaccine-janssen-epar-public-assessment-report_en.pdf
  12. A. Wolff et al. (1990). Direct Gene Transfer into Mouse Muscle in vivo. Science, 247 (4949 Pt 1), 1465-1468. https://doi.org/10.1126/science.1690918
  13. S. K. Gupta, B. J. Haigh, F. J. Griffin & T. T. Wheeler. (2013). The Mammalian Secreted RNases: Mechanismz of Action in Host Defence. Innate Immunity, 19(1), 86-97. https://doi.org/10.1177/1753425912446955
  14. H. J. Park, H. L. Ko, S. Y. Jung, H. B. Jo & J. H. Nam. (2016). The Characteristics of RNA Vaccine; its Strengths and Weaknesses. Journal of Bacteriology and Virology, 46(3), 115-127. https://doi.org/10.4167/jbv.2016.46.3.115
  15. K. Kariko, M. Buckstein, H. Ni & D. Weissman, (2005). Suppression of RNA Recognision by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Cell, 23, 165-175. https://doi.org/10.1016/0092-8674(81)90281-6
  16. Springer Nature. (2021). Messengers of Hope. Nat Biotechnol, 39, 1. https://doi.org/10.1038/s41587-020-00807-1
  17. C. Scheitz & L. Leidinger. (2021). Exploring the Supply Chain of the Pfizer/BioNTech and Moderna COVID-19 Vaccines. https://blog.jonasneubert.com/2021/01/10/exploring-the-supply-chain-of-the-pfizer-biontech-and-moderna-covid-19-vaccines/
  18. E. Cott, E. deBruyn & J. Coru. (2021). How Pfizer Makes Its Covid-19 Vaccine. New York Times. https://www.nytimes.com/interactive/2021/health/pfizer-coronavirus-vaccine.html
  19. D. Lowe. (2021). RNA Vaccines and Thier Lipids. https://blogs.sciencemag.org/pipeline/archives/2021/01/11/rna-vaccines-and-their-lipids (accessed May 24, 2021)
  20. Centers for Disease Control and Prevention. (2021). Fact Sheet for Recipients and Caregivers Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine to Prevent COVID-19 in Individuals 12 Years of Age and Older. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Pfizer-BioNTech.html
  21. Centers for Disease Control and Prevention. (2021). Fact Sheet for Healthcare Providers Administering Vaccine Energency Use Authorization of the Moderna COVID-19 Vaccine to Prevent COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
  22. C. Zeng, C. Zhang, P. G. Walker & Y. Dong. (2020). Formulation and Delivery Technologies for mRNA Vaccines, Current Topics in Microbiology and Immunology. In: Current Topics in Microbiology and Immunology. Berlin, Heidelberg : Springer. DOI: 10.1007/82_2020_217.
  23. L. A. Brito et al. (2014). A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines, Molecular Therapy, 22(12), 2118-2129. https://doi.org/10.1038/mt.2014.133
  24. M. D. Buschmann, M. J. Carrasco, S. Alishetty, M. Paige, M. G. Alameh & D. Weissman, (2021). Nanomaterial Delivery Systems for mRNA Vaccines, Vaccines, 9, 65. https://doi.org/10.3390/vaccines9010065
  25. Y. Singh et al. (2017). Nanoemulsion: Concepts, Development and Applications in Drug Delivery, Journal of Controlled Release, 252, 28-49. https://doi.org/10.1016/j.jconrel.2017.03.008
  26. H. H. Tayeb & F. Sainsbury. (2018). Nanoemulsions in Drug Delivery: Formation to Medical Application, Nanomedicine, 13(19), 2507-2525. DOI: 10.2217/nnm-2018-0088
  27. K. J. Hassett et al. (2021). Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines, Molecular Therapy: Nucleic Acids, 15, 1-11. https://doi.org/10.1038/sj.mt.6300051
  28. Moderna Extends Lipid Supply for Coronavirus Vaccine (2020). CordenPharma. https://www.cordenpharma.com/CordenPharma_and_Moderna_Extend_Lipid_Supply_Agreement_for_Moderna_Vaccine_mRNA-1273_Against_Novel_Coronavirus_SARS-CoV-2
  29. E. Gray. (2020). NASA Supercomputers Power COVID-19 Research. https://www.nasa.gov/feature/esd/2020/nasa-supercomputers-power-covid-19-research
  30. Y. Wang, Z. Zhang. X. Luo, Y. Han & X. Wei. (2021). mRNA Vaccine: A Potential Therapeutic Strategy, Molecular Cancer, 20, 33. https://doi.org/10.1186/s12943-021-01311-z
  31. M. Wadman. (2020). Will A Small, Long-shot U.S. Company End Up Producing the Best Coronavirus VAccine. Science. https://www.sciencemag.org/news/2020/11/will-small-long-shot-us-company-end-producing-best-coronavirus-vaccine DOI:10.1126/science.abf5474
  32. Advancing Medical Research. (2021). How RNA Technology Could Revolutionize Vaccine Production, Breakthroughs. https://www.breakthroughs.com/advancing-medical-research/how-rna-technology-could-revolutionize-vaccine-production